Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-07-03

Clinical Trial Update: Connect® Myeloid Disease Registry

View source ↗

Summary

The Connect Myeloid Disease Registry sponsored by Celgene has been terminated. The registry involved conditions including primary myelofibrosis, myelodysplastic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Celgene | Conditions: Primary Myelofibrosis, Myelodysplastic Syndromes | Status: TERMINATED